Black Rock Inc. Ocuphire Pharma, Inc. Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding OCUP
# of Institutions
44Shares Held
2.54MCall Options Held
2KPut Options Held
2K-
Vanguard Group Inc Valley Forge, PA992KShares$1.17 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA266KShares$313,7070.0% of portfolio
-
Richmond Brothers, Inc. Jackson, MI191KShares$225,7380.6% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX164KShares$193,2140.01% of portfolio
-
Knoll Capital Management, LLC Miami, FL100KShares$118,0000.1% of portfolio
About Ocuphire Pharma, Inc.
- Ticker OCUP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,579,800
- Market Cap $24.3M
- Description
- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...